Chief Business Officer · AbCellera Biologics Inc. (ABCL)

Neil Berkley

FY2021 is the first fiscal year CompBrief holds for Neil Berkley as a named executive officer of AbCellera Biologics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$4,571,909

Salary $194,129Stock awards $2,107,407Bonus $144,545

2nd of 5 named executive officers at AbCellera Biologics by FY2021 total.

5 named officers on file for AbCellera Biologics, FY2021

Neil Berkley’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 4 equity grants, each cited to its filing
  • ABCL’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AbCellera Biologics’s whole pay program stands against its peers

  • AbCellera Biologics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABCL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get Neil Berkley’s full pay file as a PDF — free

More than this page: up to 10 years of Neil’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Neil Berkley compensation by year

AbCellera Biologics Summary Compensation Table · the one fiscal year held
In US dollars, as AbCellera Biologics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$194,129
Bonus$144,545
Stock awards$2,107,407
Option awards$2,099,231
Non-equity incentive$0
Pension and deferred compensation$0
All other$26,596
Total$4,571,909

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbCellera Biologics Inc. DEF 14A filed April 28, 2022, accession 0001140361-22-016463, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AbCellera Biologics Inc. filed document, accession 0001140361-22-016463. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU70,000$0—
RSU68,729$0—
Option108,272—$14.55
Option105,000—$15.82

Per the Outstanding Equity Awards at Fiscal Year-End table in AbCellera Biologics Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

AbCellera Biologics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Carl HansenChief Executive Officer$9,116,252
Neil Berkley · this pageChief Business Officer$4,571,909
Andrew BoothChief Financial Officer$4,313,387
Veronique LecaultChief Operating Officer$4,313,387
Tryn StimartChief Legal Officer, Chief Compl i ance Officer & Corporate Secretary$3,063,678

The full AbCellera Biologics compensation record

free company brief

This page is one person within AbCellera Biologics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AbCellera Biologics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Neil Berkley's compensation dossier · One-time report. No refunds.